EUS Fiducial Placement for Pancreatic Cancer
Trial Summary
What is the purpose of this trial?
RATIONALE: Pancreas tumor localization makes minimally invasive surgical resection of pancreas tumors very challenging. Recently, an endoscopic ultrasound needle system has been developed which enables fiducial coils to be placed at the precise site of biopsy. INTERVENTION: At time of EUS guided biopsy the fine needle fiducial device will be used to place fiducials in the tumor. During surgery we will assess whether it improves tumor visualization. OBJECTIVES: We aim to determine the feasibility to use EUS guided fiducials placement to mark pancreas tumors in 20 patients and to assess whether the fiducials impact tumor visualization during pancreas surgery. STUDY POPULATION: Patients with pancreas adenocarcinoma or neuroendocrine lesions. STUDY ENDPOINTS: The main outcome will be to assess whether the coil may be successfully placed during EUS and whether they impact tumor visualization during surgery FOLLOW UP and ANALYSIS: Patients will be assessed at the time of EUS and surgery. This is a pilot analysis with the intention to assess feasibility and to gather data to power larger trials.
Research Team
Eligibility Criteria
This trial is for adults with pancreatic cancer who are set to have surgery. They must be undergoing an endoscopic ultrasound as part of their pre-surgery evaluation and have tumors between 5mm-4cm in size. It's not for those with blood clotting issues, metal allergies, pregnancy, under 18 years old, or diagnosed with pancreatic lymphoma.Inclusion Criteria
Exclusion Criteria
Treatment Details
Interventions
- EUS with Fiducial (Other)
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Southern California
Lead Sponsor
Dr. Samir A.
University of Southern California
Chief Executive Officer since 2024
PhD in Molecular Biology from the University of Southern California
Dr. Chung
University of Southern California
Chief Medical Officer since 2016
MD from UC San Diego